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Single-pass transmembrane receptors are involved in essential processes of
both physiological and pathological nature and represent more than 1300
proteins in the human genome. Despite the high biological relevance of
these receptors, the mechanisms of the signal transductions they facilitate
are incompletely understood. One major obstacle is the lack of structures
of the transmembrane domains that connect the extracellular ligand-
binding domains to the intracellular signaling platforms. Over a period of
almost 20 years since the first structure was reported, only 21 of these
receptors have become represented by a transmembrane domain structure.
This scarceness stands in strong contrast to the significance of these trans-
membrane a-helices for receptor functionality. In this review, we explore
the properties and qualities of the current set of structures, as well as the
methodological difficulties associated with their characterization and the
challenges left to be overcome. Without an increased and focused effort to
bring this class of proteins on par with the remaining membrane protein
field, a serious lag in their biological understanding looms. Design of phar-
maceutical agents, prediction of mutational affects in relation to disease,
and deciphering of functional mechanisms require high-resolution struc-
tural information, especially when dealing with a domain carrying so much
functionality in so few residues.
Introduction
As transmitters of vital molecules and environmental
cues to the inside of the membrane-enveloped cell,
membrane proteins play indispensable roles for all
known life forms. They constitute up to one-third of
the proteome [1,2] and are targets for more than 50%
of pharmaceutical drugs [3]—still they represent <3%
of the structures deposited in the RCSB Protein Data
Bank (PDB) [4]. One important type of membrane
protein is the single-pass transmembrane receptors
(SPTMRs), of which ~ 1300 have been identified in
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the human genome, constituting roughly 6% of human
genes [5]. This membrane protein family includes, e.g.,
the receptor tyrosine kinases (RTKs), the integrins,
and the cytokine receptors, and is involved in a variety
of biological processes ranging from metabolism,
growth, proliferation, and apoptosis to immune
responses [6–9].
The functional signaling unit of SPTMRs is usually
assembled from two or more identical or nonidentical
receptor chains. These SPTMR chains are composed
of several functional regions, divided by the membrane
into three distinct domains; the extracellular domain
(ECD), the transmembrane domain (TMD), and the
intracellular domain (ICD) (Fig. 1). Generally, the
ECDs of SPTMRs represent the longest region (up to
22 100 residues with a median of 380 residues), while
the ICDs are smaller and less conserved (up to 687
residues with a median of 56 residues) [5]. The TMDs
constitute the shortest (~ 25 residues [10]) and most
well-conserved domain [11], which connect the ECD
and ICD through its unidirectional insertion into the
membrane bilayer. The ECDs may be considered the
transceivers of the SPTMRs and have the unique abil-
ity to recognize large first messengers such as hor-
mones, cytokines, extracellular matrix proteins, and
other SPTMRs [5]. The ECDs are globular, soluble
domains and are the best characterized, while recent
studies have highlighted the high proportion of struc-
tural disorder in the ICDs of human SPTMRs [12–14].
As a response to extracellular ligand interactions, these
ICDs are modified, leading to initiation of cellular sig-
naling cascades. The majority of SPTMRs does not
possess intrinsic enzymatic activity, and instead rely on
the recruitment of adaptors and enzymes to propagate
signals [5].
The details of cross-membrane signal transduction
through SPTMRs remain largely unknown. Nonethe-
less, SPTMRs have been suggested to function by
adopting multiple conformations through ligand-
induced stabilization of specific homo- or heterodi-
meric conformations [15–18]. The high conformational
flexibility linked to this mode of action is a fascinating
trait of these receptors, allowing delicate local rear-
rangements to govern the behavior of large and com-
plex signaling pathways. However, this high
conformational flexibility along with their diverse
structural composition also makes SPTMRs notori-
ously difficult to characterize structurally [19], and no
high-resolution structure of any intact SPTMR has
been solved to date. As an alternative, a divide-and-
conquer approach is often evoked in structural studies
of these proteins, which may be combined with com-
putational modeling [17,20]. Even though a divide-
and-conquer strategy should always be applied with
care, it is justified for the TMDs by the two-stage
(three-step) model of membrane protein folding [21],
highlighting that TMD a-helices are independently
stable domains, as well as several studies demonstrat-
ing that TMDs may preserve their native fold when
separated from adjacent domains [22–24].
Accumulating evidence suggests that the membrane-
embedded TMDs of SPTMRs regulate receptor chain
associations as well as cross-membrane signal trans-
duction by changing conformation or oligomerization
ICD
TMD
ECD
hPRLR
hPRL
Fig. 1. Topology of an SPTMR, here exemplified by the human PRLR [20]. The membrane-embedded part of the receptor is colored pink,
while the water-soluble domains are blue. Two conserved sequence motifs, Box1 and Box2, are orange, and three recently identified lipid
interaction domains [14] are cyan. The hormone ligand prolactin (PDB code 1RW5 [108]) is shown in green and marked PRL, while the
membrane bilayer is represented by a pale blue box. The active complex is a 1 : 2 complex and the two SPTMRs comprise three main
domains: the extracellular domain (ECD), the transmembrane domain (TMD), and the intracellular domain (ICD).
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status [15,18,19,25,26], placing the single-pass TMDs
in the center of cross-membrane SPTMR functionality.
This essential role is further highlighted by the discov-
ery of mutations in the TMDs or the TMD-juxtamem-
brane (JM) boundary regions that are associated with
severe diseases [7,27,28]. Furthermore, several studies
have demonstrated how the activity of specific
SPTMRs may be controlled by small peptides that
specifically recognize their TMDs, and thereby inter-
fere with their lateral association within the membrane
[29–31]. Due to this decisive role in receptor function-
ality and the conserved nature of the TMDs, SPTMR-
TMDs represent a promising class of pharmacological
targets. Perplexingly, the number of atomic resolution
structures of SPTMR-TMDs has remained persistently
low, and the functionality and molecular details of
these domains therefore remain enigmatic. Currently,
this leaves the modus operandi of SPTMRs unresolved.
In an attempt to identify the missing pieces in the
puzzle of transmembrane signaling, we here assess the
structural landscape of mammalian SPTMR-TMDs
and discuss the progress and challenges revealed by
the limited number of structural studies conducted
over the last two decades. We mainly focus on the
monomeric and homodimeric TMD structures, the
transition between them and their interactions, which
have implications for receptor assembly as well as
functionality. An increasing effort in the field within
the last 5 years has brought the total number of
unique SPTMR-TMDs represented by monomeric
and/or homodimeric structures in the PDB up to 21
(represented by 31 PDB structures). Structures of three
additional SPTMR-TMDs have been deposited in the
PDB (2M3E, 2MIC, 2MJO), but as no information
regarding the details of, e.g., data acquisition and
structure calculation methods have been published,
they are not considered further in this review. This
means that <2% of the TMDs from this class of mem-
brane proteins have been structurally characterized,
and the diversity of the receptor families represented is
consequently limited. The majority of the solved struc-
tures belongs to the RTKs [the ephrin receptor (Eph),
the epidermal growth factor receptor (ErbB), the
fibroblast growth factor receptor (FGFR), the vascular
endothelium growth factor receptor (VEGFR), and
the platelet-derived growth factor receptor (PDGFR)
families], while a few immunoreceptors, integrins, and
class I cytokine receptors are represented along with
one member of the glycophorin (GP) and amyloid pre-
cursor-like protein (APLP) families, respectively. This
review will highlight that the road toward a full, struc-
ture-based mechanistic understanding of SPTMR-
TMDs is still long and littered with obstacles.
Single-pass TMDs and their structures
Currently, the dominating methods for atomic resolu-
tion structural studies of proteins are X-ray crystallog-
raphy, solution-state nuclear magnetic resonance
(NMR) spectroscopy, solid-state NMR spectroscopy
and electron microscopy. While ~ 90% of all structures
deposited in the PDB have been solved by X-ray crys-
tallography [32], solution-state NMR spectroscopy has
exclusively been used to determine the 31 published
structures of monomeric and homodimeric SPTMR-
TMDs. The first SPTMR-TMD structure was solved in
1997 of the glycophorin A (GpA) TMD in its homod-
imeric form [33], demonstrating the applicability of
solution-state NMR spectroscopy to this particular
domain of SPTMRs. The reason for the dominance of
solution-state NMR spectroscopy is probably its high
suitability for characterizing small, dynamic proteins,
in combination with the challenges associated with
crystallizing membrane proteins. Nonetheless, solution-
state NMR spectroscopy imposes very specific require-
ments. First, the protein of interest should be isotope-
labeled, currently essentially restricting production to
entail recombinant expression in E. coli or potentially
in yeast or by cell-free synthesis [34]. Furthermore,
solution-state NMR spectroscopy is restricted to small-
sized systems (below ~ 100 kDa), limiting the selection
of membrane mimetics significantly. Within the cur-
rently feasible size range is, e.g., organic solvents, deter-
gents, and bicelles, where the latter two represent the
most widely used systems to solubilize membrane pro-
teins for NMR studies. Several excellent reviews are
available describing the broader palette of membrane-
mimicking solvents for solution-state NMR spec-
troscopy [35–39] as well as detailing the process of
structure determination of membrane proteins by this
technique [40–43]. Importantly, it is well established
that membrane mimetics may influence the quality of
the collected data as well as the structural properties of
membrane proteins significantly [44], and it is likely
that certain types of helix–helix interactions are exag-
gerated or reduced in membrane mimetics of varying
types [45]. Currently, no robust method for predicting
which membrane-mimicking solvent will be most suit-
able for a specific membrane protein exist; this parame-
ter needs to be optimized in each individual case.
Evaluating the quality of the NMR data of the protein
in various membrane mimetics is, however, relatively
straightforward from analysis of 1H,15N-HSQC spectra.
When it comes to evaluating whether the structure is
perturbed under the applied conditions relative to the
native structure, the most reliable measure is conserva-
tion of biological activity. However, in case of SPTMR-
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TMDs, biological activity is currently only measurable
in the context of the full receptor within the cell. For
example, ligand binding to the ECD may be uncoupled
from signaling to the ICD, and vice versa, demonstrat-
ing that such biochemical assays do not guarantee the
TMD to exist in the correct signaling-competent confor-
mation. Thus, this approach is critically unfeasible as a
screening methodology for evaluating the SPTMR-
TMDs in different membrane mimetics compatible with
NMR studies. Adding to this, SPTMR-TMDs have a
higher surface-to-volume ratio than multi-pass mem-
brane proteins, likely causing an increased sensitivity to
the surrounding solvent. Use of membrane mimetics in
structural studies of these domains therefore requires
careful evaluation of putative effects on the structure
and obtained data.
Monomeric TMD structures
The TMD of 10 SPTMRs is represented by a mono-
meric structure in the PDB (Fig. 2). Of these, three
belong to the integrin (Int) family (IntaI [46], Intb3
[47], IntaIIb [48]), three are RTKs (insulin receptor
(IR) [49], ErbB1[50], ErbB2 [51]), two are class I cyto-
kine receptors (the erythropoitin receptor (EPOR)
[52,53] and the prolactin receptor (PRLR) [20]), one
member is an immunoreceptor (cluster determinant 4
(CD4) [54]), and one belongs to the APLP family
(amyloid precursor protein (APP) [55,56]). The EPOR
is represented by two similar murine (2MXB [53]) and
human (2MV6 [52]) TMD structures, while the APP-
TMD structure has been determined by two different
groups (2LLM [55] and 2LP1 [56]). All the monomeric
structures consist of one main a-helix harboring 24–35
residues, encompassing the region bioinformatically
predicted to be the TMD [57]. The TMD structures of
CD4, ErbB1, and mErbB2 also have minor C-terminal
JM a-helices of 13, 9, and 7 residues, respectively, con-
nected to the main helix by 10 (CD4)- or 3-residue
loop regions (Fig. 2). The mEPOR-TMD and the two
APP-TMD structures have minor N-terminal a-helices
that are between 7 and 10 residues, connected to the
main helix by a short loop region (Fig. 2).
The majority of the monomeric TMD structures
appear to have some degree of curvature, with only
the EPOR-TMDs, the Intb3-TMD, and the IntaIIb-
TMD represented by completely straight a-helices
(Fig. 2). Excluding one of the APP-TMD structures
(2LP1), the remainder has various degrees of subtle
kinks only slightly changing the direction of the helix
axis. However, one of the APP-TMD structures
(2LP1) has a significant kink near the center of the
TMD helix of ~ 30°, mainly caused by a Gly-pair. The
curved nature of this TMD is believed to be crucial
for recognition and proteolysis by c-secretase [56]. The
other structure of the APP-TMD monomer (2LLM)
only possesses a slight bend at the same position.
Homodimeric TMD structures
The TMDs of 14 SPTMRs are represented by a
homodimer structure in the PDB (Fig. 3). Nine of
A  mEPOR 
(2MXB)
G  Int ᾳI 
(2L8S)
H  Int β3 
(2RMZ)
D  IR 
(2MFR)
C  PRLR 
(2N7I)
F  mErbB2 
(1IIJ)
K  APP 
(2LLM)
E  ErbB1 
(2N5S)
B  EPOR 
(2MV6)
I  Int ᾳIIβ 
(2K1A)
J  CD4 
(2KLU)
L  APP 
(2LP1)
Fig. 2. Currently available monomeric
structures of mammalian SPTMR-TMDs.
The pale blue box represents the
membrane bilayer hydrocarbon layer of
~ 30 A. Residues with hydrophobic side
chains are gray, polar are green, positively
charged are red, negatively charged are
blue. Cys, Gly, and Pro are orange. (A)
mouse (m) EPOR-TMD (2MXB), (B) EPOR-
TMD (2MV6), (C) PRLR-TMD (2N7I), (D) IR-
TMD (2MFR), (E) ErbB1-TMD (2N5S), (F)
mErbB2-TMD (1IIJ), (G) Integrin aI-TMD
(2L8S), (H) Integrin b3-TMD (2RMZ), (I)
Integrin aIIb-TMD (2K1A), (J) hCD4-TMD
(2KLU), (K) APP-TMD (2LLM), (L) APP-TMD
(2LP1).
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these are RTKs (ErbB1-4 [15,58–62], FGFR3 [63],
PDGFR [64], VEGFR2 [23], EphA1-2 [65,66]), three
are immunoreceptors (lymphoid/myeloid receptor sig-
naling module (DAP12) [67], the f chain (ff) [68],
Toll-like receptor 3 (TLR3) [69]), one belongs to the
APLPs (APP [70,71]), and one belongs to the GP fam-
ily (GpA [33], [72]). Two similar homodimer structures
exist of the GpA-TMD and the APP-TMD (1AFO
[33] and 2KPF/2KPE [72] for the GpA and 2LOH [71]
and 2LZ3 [70] for the APP), which in each case have
C  GpA
(1AFO)
J  ErbB4
(2LCX)
H  ErbB2
(2JWA)
E  EphA1
(2K1L)
D  GpA
(2KPF)
B  TLR3
(2MK9)
F  ErbB1
(2M20)
A  APP
(2LZ3)
M  FGFR3
(2LZL)
Q  APP
(2LOH)
P  DAP12
(2L34)
R  EphA2
(2K9Y)
N  ErbB3
(2L9U)
L  PDGFR
(2L6W)
O  ζζ
(2HAC)
K  VEGFR2
(2M59)
Le
ft-
ha
nd
ed
Le
ft-
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nd
ed
R
ig
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an
de
d
R
ig
ht
-h
an
de
d
I  ErbB2
(2N2A)
G  ErbB1
(2M0B)
Fig. 3. Currently available homodimer structures of mammalian WT SPTMR-TMDs. The right-handed structures are shown in the two top
panels, while the left-handed structures are shown in the two bottom panels. The pale blue box represents the membrane bilayer
hydrocarbon layer of ~ 30 A. Residues with hydrophobic side chains are gray, polar are green, positively charged are red, negatively charged
are blue. Cys, Gly, and Pro are orange. Residues involved in interhelical interactions are shown as sticks. (A) APP-TMD (2LZ3), (B) TLR3-
TMD (2MK9), (C) GpA-TMD (1AFO), (D) GpA-TMD (2KPF), (E) EphA1-TMD (2K1L), (F) ErbB1-TMD (2M20), (G) ErbB1-TMD (2M0B), (H)
ErbB2-TMD (2JWA), (I) ErbB2-TMD (2N2A), (J) ErbB4-TMD (2LCX), (K) VEGFR2-TMD (2M59), (L) PDGFR-TMD (2L6W), (M) FGFR3-TMD
(2LZL), (N) ErbB3-TMD (2L9U), (O) ff-TMD (2HAC), (P) DAP12-TMD (2L34), (Q) APP-TMD (2LOH), (R) EphA2 (2K9Y).
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been solved by different groups, while two different
homodimer structures have been solved of the ErbB1-
TMD (2M20 [15] and 2M0B [62]) and the ErbB2-
TMD (2JWA [58] and 2N2A [61]).
The TMD homodimer structures all consist of two
main a-helices harboring 23–38 residues each, and
include the regions bioinformatically predicted to be
the TMD [57]. The ErbB1-TMD structure 2M20 and
the ErbB2-TMD structure 2N2A have additional
minor C-terminal JM a-helices of 11 and 15 residues,
respectively, connected to the main helix by a three-
residue loop (Fig. 3). Like the monomeric structures,
the majority of the homodimeric structures have subtle
kinks or concave helices, while four structures appear
to have straight helices (EphA1-TMD, EphA2-TMD,
ErbB2-TMD, GpA-TMD) (Fig. 3). The VEGFR2-
TMD structure represents a special case having two
convex helices, resulting in a slight bending of the two
helices moving through their entire length. The
FGFR3-TMD structure stands out by forming a con-
cave helix in the bioinformatically predicted TMD
region, interrupted by an N-terminal kink before
another four residues resume the helix. Likewise, the
APP-TMD structure (2LZ3) has both an N-terminal
and C-terminal kink. The remaining structures have
one minor kink each, but none as severe as the mono-
meric APP-TMD structure (2LP1). The majority of
these kinks occur in proximity to Gly residues, while a
few are adjacent to Ser and/or Thr.
Extent of the TMD a-helix
Upon closer inspection of the monomeric and
homodimeric SPTMR-TMD structures, we noted that
the Uniprot annotated TMD regions [57] often only
partially describe the region that was experimentally
determined to be helical. Some of the more pro-
nounced examples are the mEPOR-TMD and the
hEPOR-TMD in which 10 additional helical residues
extent the annotated TMD region C-terminally, while
the ErbB1-TMD structure 2M20, the ErbB3-TMD
structure, and the VEGFR2-TMD structure are
extended by a total of 9, 12, and 16 residues, respec-
tively. In the full protein, some of the TMDs may
have even longer a-helices than experimentally deter-
mined, as the TMD constructs have been terminated
close to the observed helix-border (e.g., the
VEGFR2-TMD which is a-helical throughout its
length). The Uniprot annotation of TMD regions is
performed by applying the TM helix predictor
TMHMM [73] as a Yes/No criterion. The sequence
positions are subsequently assigned by the hydropho-
bic moment plot method of Eisenberg et al. [74] pro-
viding an average TMD length of 21 residues.
However, the Uniprot annotated TMD regions are
on average ~ 20% shorter than the TMD a-helix of
the NMR structures. To further understand this
observation, the complete receptor sequences includ-
ing the extra- and intracellular parts were submitted
directly to the TMHMM- [73], Phobius- [75,76], and
MEMSAT3 [77] webservers (Figs 4 and 5), which are
three commonly applied secondary structure and
topology predictors for all-helical transmembrane pro-
teins. Overall, the results of these predictors suggested
shorter a-helices than was observed in the NMR
structures (Fig. 4), with the MEMSAT3 predictor
seemingly providing the results overall closets to the
NMR structures. When the results of the predictors
were inspected more closely, it became evident that
the predicted TMD a-helices were often shorter C-
terminally compared to the NMR structures (Fig. 5).
It should additionally be noted that TMHMM sug-
gested a second TMD region for the mErbB2, ErbB1,
ErbB2, ErbB4, FGFR3, and VEGFR2, which if cor-
rect would place their intracellular domains on the
extracellular side.
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Fig. 4. Number of residues in the TMD a-helix of the NMR
structures plotted against the bioinformatically predicted number of
residues in the TMD. The results from four different predictions
have been used as x-coordinates; TMHMM [73] (light blue),
Phobius [75,76] (red), MEMSAT3 [77] (purple), and Uniprot
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structures represented by a cross located above the dashed line
have longer a-helices than predicted, and vice versa.
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512 534
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 EIT-------RRL
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 NKG--------KKK
    AII--VML    AII--VML   GAI--LVM   GAI---VML
681 709
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2LOH
 KTN----------------NGG
    LEI---VII      III---ILR      III-VII      III-VII
741 776
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2M59
   ATG------RRH
  IAT---LFM  IAT--GLF SIA-----FMR  IAT--LFM
623 648
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23222523
2N5S
 PSI-----------IVR
   IAT--LFM   IAT-GLF  SIA----FMR   IAT--LFM
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32
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The origin of the discrepancy between the results
of the applied secondary structure and topology pre-
dictors and the NMR structures of the SPTMR-
TMDs remains to be understood. However, it seems
that especially Uniprot and the TMHMM predictor
operate with a very narrow definition of the length
of a membrane spanning helix (21–23 residues,
Fig. 4), which intuitively would be expected to vary
with, e.g., cell membrane composition and helix tilt
angle. Another potential issue may reside in distor-
tions of the TMD peptides brought on by the mem-
brane mimetics, or simply that the a-helical region is
not restricted to the hydrocarbon core, and could
extend into the polar regions of the bilayer as well
as into the inside and outside of the cell. In this
regard, it should be remembered that the ~ 30 A
hydrocarbon core of a membrane bilayer is sur-
rounded by two head group regions each having a
thickness of ~ 15 A with no sharp boundaries [38].
Interestingly, the different structures determined of
the ErbB1-TMD (2M20, 2M0B, 2N5S) vary consider-
ably in the extent of the TMD a-helix. The TMD a-
helix of the monomeric (2N5S) and dimeric (2M0B)
structures solved in DPC micelles harbor 26 and 25
residues, respectively, compared to 32 residues of the
dimeric structure solved in bicelles (2M20). This may
suggest that the length difference is connected to dif-
ferences in the membrane mimetics, with the bicelles
having a thicker hydrocarbon core which could favor
a longer a-helix. On the other hand, the dimeric
structures of the ErbB2-TMD (2N2A) and the GpA-
TMD (2KPE/1AFO) solved in DPC micelles harbor
31 and 27 residues, respectively, in the TMD a-helix
compared to 30 and 26, respectively, in bicelles
(2JWA and 2KPF). Of further note, the a-helix of
the ErbB3-TMD structure continues into the non-
native His-tag placed at its C terminus, suggesting a
non-native extension of the helix. Although the origin
of the discrepancies in the extent of the TMD a-helix
remains to be elucidated, these observations nonethe-
less have important implications for the design of
TMD peptides for, e.g., NMR studies and may
suggest problems with the nativeness of the solved
SPTMR-TMD structures.
Helix packing of the TMD homodimers
Two a-helices may acquire close packing by interleaving
their side chains in the ‘knobs into holes’ [78] or ‘ridges
into grooves’ [79] arrangements. The steric limitations
of these arrangements favor specific crossing angles, and
in 1977, Chothia et al. [79] introduced the three basic
helix packing types defined by crossing angles; (a) a
mean angle between the helix axes of  82°, (b) a mean
angle between the helix axes of  60°, and (c) a mean
angle between the helix axes of + 19°. These helix cross-
ing angles are the most favorable for close helix packing,
but the observed crossing angles often differ slightly due
to variations in side-chain volumes.
The currently solved SPTMR-TMD homodimer
structures have an almost equal distribution of type II
and III packing angles (Fig. 6, Table 1), while no
examples of type I packing angles have been pub-
lished. The current structures may therefore be divided
into two main groups; group II containing the homod-
imers with type II helix packing angles resulting in
right-handed crossing, and group III having type III
helix packing angles resulting in left-handed crossing.
It is, however, noted that three right-handed structures
(2LZ3, 2M0B, 2N2A) have a helix crossing angle
which is significantly higher than the remainder of the
group (Fig. 6, highlighted with ‘*’).
The ideal group II homodimers are the TMD
structures of TLR3, EphA1, ErbB1 (2M20), ErbB2
(2JWA), ErbB4, and GpA (Table 1, Fig. 3B–F,H,J).
The dimeric TMD structures of APP (2LZ3), ErbB1
(2M0B), and ErbB2 (2N2A) are denoted II* due to
their unusual helix crossing angles (Table 1, Fig. 3A,
G,I), and they are therefore considered as a separate
subgroup of group II. The ideal group II structures
are characterized by a right-handed crossing of their
a-helices resulting in a relatively large crossing angle
(average crossing angle of  41°) and smaller con-
tact surfaces (average of ~ 400 A2) (Table 1).
Fig. 5. Schematic overview of the extent of the TMD a-helices determined by NMR spectroscopy and predicted bioinformatically.
Alignment of the three first and the three last residues of the TMD a-helix as determined by NMR spectroscopy (black), or the predictors
TMHMM [73] (light blue), Phobius [75,76] (red), MEMSAT3 [77] (purple), or Uniprot annotations (green) [57,74]. The numbers to the left of
the sequences are the number of residues in each sequence. The gray cylinders represent the relative length of the TMD a-helix as
determined by NMR spectroscopy with the sequence number of the first and last residue in the TMD a-helix as well as the PDB code
given. (A) CD4 (2KLU), (B) mEPOR (2MXB), (C) EPOR (2MV6), (D) PRLR (2N7I), (E) IR (2MFR), (F) mErbB2 (1IIJ), (G) Integrin aI (2L8S), (H)
Integrin b3 (2RMZ), (I) DAP12 (2L34), (J) ff (2HAC), (K) Integrin aIIb (2K1A), (L) ErbB3 (2L9U), (M) ErbB4 (2LCX), (N) FGFR3 (2LZL), (O)
PDGFR (2L6W), (P) EphA1 (2KIL), (Q) EphA2 (2K9Y), (R) GpA (1AFO/2KPE), (S) GpA (2KPF), (T) TLR3 (2MK9), (U) APP (2LPI), (V) APP
(2LLM), (X) APP (2LZ3), (Y) APP (2LOH), (Z) VEGFR2 (2M59), (Aa) ErbB1 (2N5S), (Bb) ErbB1 (2M20), (Cc) ErbB1 (2M0B), (Dd) ErbB2
(2JWA), (Ee) ErbB2 (2N2A).
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Consequently, they have a similar overall topology
(Fig. 6). Their relatively large crossing angles and
small contact surfaces are the result of small-residue
motifs commonly encountered in this packing group,
which is described further below. In addition, the
ideal type II dimers are most separated C-terminally
toward the cytoplasmic side, with an average dis-
tance between the a-helix C terminus of ~ 20 A
compared to ~ 11 A for the N terminus. In contrast,
the unusual type II* dimers share, except for the
right-handedness, many of their characteristics with
the left-handed group, such as an almost parallel
conformation and bigger contact surfaces.
The group III structures are the TMDs of EphA2,
ff, APP (2LOH), ErbB3, PDGFR, VEGFR2,
FGFR3, and DAP12 (Table 1, Fig. 3K–R). These
homodimers are characterized by a left-handed cross-
ing of their a-helices (average crossing angle of 26°),
bigger contact surfaces (average of ~ 590 A2), and
smaller terminal gaps (Table 1), and consequently,
like group II, share a similar overall topology (Fig. 6).
The a-helical dimers with a left-handed crossing some-
times employ heptad-like dimerization motifs and are
also known as ‘coiled-coils’ [80,81]. It is noted that
the two dimer structures of the APP-TMD (2LZ4 and
2LOH) fall into different packing groups, which will
be discussed below.
Motifs and interactions in the
homodimeric TMD structures
Sequence motifs and the forces driving helix–
helix assembly
To ensure specific assembly of the SPTMRs, the TMDs
must present specific complementary recognition
domains. Although specificity between soluble domains
often is achieved by large recognition interfaces
(~ 800 A2 [82,83]), the small size of single-pass TMDs
represents a unique challenge to specificity. The achieve-
ment of a sufficient affinity and specificity in these small
domains have so far mainly been attributed to recurrent
sequence motifs, characterized by specific amino acid
patterns. Consequently, an extensive amount of effort
has been put into identifying and recognizing motifs in
the primary structure of TMDs [27,84–86], and cur-
rently, the most studied interaction motifs for TMDs
are the so-called GAS and heptad motifs.
The GAS-motif, which is found in ~ 57% of all
TMDs [87], is a five-residue small-x3-small residue
–40° +20°
Left-handed:
- Bigger contact surfaces
- Smaller terminal gaps
Right-handed:
- Smaller contact surfaces
- Bigger terminal gaps
–55 –45 –35 –25 –15 –5 5 15 25 35 45 55
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*
Fig. 6. The two different topology groups of
the current SPTMR-TMD homodimer
structures. The current SPTMR-TMD
homodimer structures can be divided into
two groups: group II with type II crossing
angles and right-handed helix crossing, and
group III with type III crossing angles and
left-handed helix crossing. Top: Histogram
of the helix crossing angle distribution in the
19 unique homodimer structures. The
crossing angles of the APP-TMD
homodimer 2LZ3, the ErbB1-TMD
homodimer 2M0B, and the ErbB2-TMD
homodimer 2N2A are outliers, and their bar
is highlighted with ‘*’. Middle: Backbone
alignment of the TMD-a-helices of the left-
and right-handed structures (2LZ3, 2M0B
and 2N2A left out), respectively, in ribbon
representation. Bottom: Schematic
representation of the two topology groups.
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motif with the small residue dominantly being G, but
occasionally also A or S. The GAS-motif is also
known as the GASright-motif, as it is responsible for
the right-handed helical associations of parallel dimers.
The Gx3G version of this motif is the most common
[87], and is often found in i  1 or i  2 association
with large aliphatic residues (I, V, and L) [88]. The
structural rationale behind the high implication of
GAS-motifs in TMD oligomerization is rooted in its
propensity for formation of stabilizing interhelical car-
bon hydrogen bonds, occurring between Ca-Ha donors
and backbone carbonyl oxygen acceptors (Ca-
HaO=C) [89,90]. The small residues in the GAS-
motif allow close proximity of the opposing helical
backbone, enabling the formation of the interhelical
backbone carbon hydrogen bonds, as well as proximity
between the main-chain and hydrogen-bonding donors
such as Ser [89]. Although Gx3G is often regarded as a
dominating dimerization motif, nonstructural studies
on the affinity of TMD dimers harboring Gx3G motifs
indicated that these motifs are neither necessary nor
sufficient for TMD dimerization [45,87]. Furthermore,
no correlation between the measured dimerization
propensity and the presence of GAS-motifs has been
found [87], as e.g., established in a study using the
TOXCAT assay to investigate the dimerization
propensity of 58 RTK TMDs in a bacterial membrane
[91].
In the heptad motif, also referred to as the leucine
zipper or GASleft motif, the interacting residues form a
repeated motif of seven residues (abcdefg) [81,92,93].
The heptad motif is responsible for formation of left-
handed coiled-coil packing, and in soluble proteins,
nonpolar residues are usually found in positions a and
Table 1. Characteristics of available WT SPTMR-TMD homodimer structures.
PDB
code Abbrev. Solvent Orientation Motif
Helix
crossing
angle
Helix
packing
group
Contact
surface
area (A2)
Dist.
Nt (A)
Dist.
Ct (A)
Nt 
Ct (A) State Ref.
2MK9 TLR3 DPC R Fx3Tx3LIx2FIx2L  51.1 II 380  20 12.7 23.4  10.7 OFF [69]
2K1L EphA1 Bicelle R AVx2GLx2GAx2LL  50.0 II 530  30 13.2 16.1  2.9 ON [65]
2M20 ErbB1 Bicelle R TGx2GA x2LLx2V  44.4 II N/A 11.6 20.7  9.1 ON [15]
2LCX ErbB4 Bicelle R PLx2AGx2GGx2ILx2Vx3F  43.3 II 360  30 13.1 27.5  14.4 ON [60]
2JWA ErbB2 Bicelle R Tx3Sx2VGx2LVx2Lx3F  41.8 II 360  30 13.8 21.3  7.5 ON [58]
2KPF GpA Bicelle R Ex2LIx2GVx2GVx2TIx2I  38.0 II 380  20 7.5 20.2  12.7 – [72]
1AFO GpA DPC R Ex2LIx2GVx2GVx2Tx3I  39.2 II 400 6.9 18.5  11.6 – [33]
2KPE GpA DPC R Ex2LIx2GVx2GVx2TIx2I  36.9 II 370  20 7.4 21.0  13.6 – [72]
2M0B ErbB1 DPC R Mx2ALx2LLx2ALx2GLx2R  26.8 II* 670  40 14.0 11.9 + 2.1 OFF [62]
2LZ3 APP DPC R Ix3Mx2GVx2Ax2IVx2L  25.4 II* N/A 16.6 13.8 + 2.8 – [70]
2N2A ErbB2 DPC R Ix3Vx2LLx2VLx2VFx2L  23.1 II* 420 15.9 21.3  5.4 OFF [61]
2K9Y EphA2 Bicelle L LAxIGx2AVxVVx2LVx5FF + 15.2 III 490  30 5.6 9.6  4.0 – [66]
2HAC ff 5 : 1
DPC :
SDS
L Cx3Dx2Lx2Yx3LTx2Fx2V + 20.0 III 576 13.0 16.3  3.3 – [68]
2LOH APP DPC L Ix3Mx2Gx3Ax2Ix3Lx2L + 22.6 III 660  60 18.3 10.5 + 7.8 – [71]
2L9U ErbB3 DPC L Ix2LVxIFx2Lx3FLx2R + 24.9 III 480  40 17.9 18.8  0.9 ON [59]
2L6W PDGFR DPC L Vx3Ax2Ax2VLx2Ix3Ix2M + 25.4 III 12.8 14.3  1.5 – [64]
2M59 VEGFR2 DPC L Tx2Ex2ILx2TAx2Ax2
FWxLLx2Ix3V
+ 26.7 III 613  20 11.4 11.8  0.4 OFF [23]
2LZL FGFR3 9 : 1
DPC :
SDS
L YAx2Lx2Gx2
FFx2ILx2Ax2TL
+ 32.1 III 870  40 14.2 15.3  1.1 OFF [63]
2L34 DAP12 LA L Lx2IVxGDx2LTx2Ix3V + 33.0 III 440  9 7.3 11.9  4.6 – [67]
Abbrev.: Short abbreviated name for the receptor of the TMD. Orientation: R is right-handed and L is left-handed. Motif: residues involved in
the interhelix interactions. Helix crossing angle: the angle between the helix directional vectors as defined at the point of crossing. Helix
packing group: assignment as defined by the crossing angle. Contact surface area: helix–helix contact surface area as calculated by the
authors of the structure. Dist. Nt: average distance between the N terminus of the TMD a-helices in each structural ensemble. Dist. Ct:
average distance between the C terminus of the TMD a-helices in each structural ensemble. Nt  Ct: difference between the average dis-
tances of the N and C termini. A negative difference means that the C-terminus of the TMD a-helices are furthest apart, and vice versa.
State: signifies if the structure has been assigned to a specific receptor state, here ON for active and OFF for inactive. Ref.: reference
describing the structure determination.
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d, forming the hydrophobic core of the helix–helix
interface, while position e and g often hold charged
residues, forming salt-bridges to each other as well as
hydrophobic contacts to the core residues [81,92,93].
However, the name GASleft has been earned as posi-
tions a and d in TMD pairs may also be occupied by
small residues (e.g., G, A, S, C) [27]. The b, c, and f
positions are on the outside of the interface, in contact
with the solvent, which in the case of TMDs is the
lipid/detergent. Critics of the TMD-heptad motifs
argue that due to the low diversity of amino acids in a
TMD region, heptad motifs can almost always be
assigned regardless of any true relevance [45]. Further-
more, charged residues, classically found at position e
and g, are rarely found within the membrane-
embedded region.
The two motifs described above do, however, not
account for all TMD–TMD helix associations. A
much more diverse range of physical interactions
including van der Waals’, aromatic p–p, cation–p, and
polar interactions [38,45,94,95] act to stabilize helix–
helix associations in the membrane environment, an
observation underlined further in the following.
Interaction motifs in the SPTMR-TMD
homodimers
Of the 17 homodimer TMD structures in Table 1, 11
are categorized as right-handed (type II/II*) and 8 as
left-handed (type III). The residues involved in inter-
molecular interactions in the dimers are positioned
with specific spacings, serving to place them on the
same side of the a-helix to form a recognition surface.
These appear most frequently to be two-residue spac-
ings (XxxX), less frequently three-residue spacings
(XxxxX), one-residue spacings (XxX), and only in a
few cases with longer spacing. The average number of
interhelical interaction residues in the structures is 8.7
residues per a-helix (7–10 residues) for the right-
handed structures, and 9.6 residues per a-helix (7–12
residues) for the left-handed structures.
The right-handed group is dominated by GAS-
motifs (employed by 7/9 unique interaction interfaces),
but even though these motifs are often highlighted as
the defining dimerization motif, other residues are cru-
cial for stabilizing the packing. This role appears pri-
marily to be filled by residues with large, hydrophobic
side chains (Leu, Ile, Val, Phe, Met). The right-handed
GAS-mediated structures typically have the small-x3-
small motif at the site of helix crossing, ensuring close
packing at the crossing site, with a helix crossing angle
clustering around  40° (Fig. 6). The right-handed
dimer conformations which do not utilize GAS-motifs
are the TLR3-TMD (2MK9) and the ErbB2-TMD
(2N2A) structures. In the TLR3-TMD dimer, the resi-
dues Fx3Tx3LIx2FIx2L constitute the helix–helix inter-
face, which is stabilized by van der Waals’ interactions
between the bulky side chains and stacking of the phe-
nyls [69]. Interestingly, the polar cluster N709TS711 is,
aside from the Thr, not directly involved in dimeriza-
tion, but seems to be responsible for kink-formation,
bringing two Phe’s (at position 706) in proximity.
These observations highlight how small residues may
act to change the overall geometry in other ways than
simply allowing close packing of the backbones. In the
ErbB2-TMD dimer (2N2A), the residues
Ix3Vx2LLx2VLx2VFx2L make up the helix–helix inter-
face with packing of this highly hydrophobic motif
mediated by van der Waals’ contacts [61]. In addition,
the 2N2A structure also describes dimerization of the
C-terminal JM of the ErbB2 through the motif
TMx2LLx2T [61].
Classical GAS-motifs do not participate in the left-
handed group (except for the APP-TMD), where the
interaction motifs sometimes can be assigned to heptad
motifs. Small residues nonetheless play a role in the
left-handed structures, but in the form of the small-x2-
small motif (henceforth termed GASshort) at the helix
crossing site, resulting in crossing angles clustering
around ~ 20° (Fig. 6). Thus, it appears that when a
small-residue motif is part of the interaction motif, the
spacing between the small residues dictate topology
and hence into which group the homodimer will pack.
However, the diversity among the interaction motifs of
the left-handed dimers varies more than the right-
handed. Even though the small residues Ala and Thr
(and Gly) are found in 7/8 of the left-handed struc-
tures, they are not always found in pairs of two at the
site of helix crossing. This is true for the TMDs of ff,
FGFR3, DAP12, and APP (2LOH, discussed further
below). The ff-TMD represents a special case where a
disulfide bridge holds the two helices together at the N
terminus. The FGFR3-TMD helices cross at a single
Gly, but no other small residues are found in the inter-
action interface (Table 1, Fig. 7). Consequently, the
structure has a very distinct curvature, with the N ter-
minus bending away from the overall direction of the
helix axis (Fig. 3M). The DAP12-TMD interface is
mediated by an Asp residue resulting in an almost par-
allel configuration that ends up in a left-handed kink
(Fig. 3P). For the PDGFR-TMDs, it was found that a
long stretch of residues (Vx3Ax2Ax2VLx2Ix3Ix2M)
make up the interaction surface [64]. Included here is
an Ax2A motif, ensuring close association at the cross-
ing site and left-handed packing. The ErbB3-TMD is
the only left-handed structure without any small
4434 The FEBS Journal 283 (2016) 4424–4451 ª 2016 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies.
Single-pass transmembrane domain structures K. Bugge et al.
residues in the interaction interface, even though its
primary structure harbors Gly, Thr, and Ala (Fig. 7).
Instead, the interactions of the ErbB3-TMDs rely on
van der Waals’ packing and p–p stacking between aro-
matic side chains and between these and the positively
charged side chain of Arg. Although many more struc-
tures are indeed needed to fully define the left-handed
family of TMD homodimers, the GASshort (small-x2-
small with small being Ala or Gly) motif and stabiliza-
tion from residues with large side chains seems to
account for the more ideal left-handed packings. Inter-
helix stabilization by aromatic side chains is also com-
mon in the structures, occurring in approximately half
of all the structures, with a slightly higher frequency in
the left-handed group (Table 1).
Currently, the dominating paradigm is that the
small-residue sequence motifs dictate the interactions
of TMDs, a concept that is not widely applied in the
prediction and analysis of oligomerization in soluble
proteins [45]. The sequence motif paradigm, while
being able to explain some interactions in TMD
homodimers, is increasingly being recognized as an
oversimplification of the intricate atomic structures
and interactions that are not yet fully understood
[45,87]. From the structures solved of the mammalian
SPTMR-TMDs reviewed here, specific residue motifs
may explain predisposition for the packing, whereas
the packing does not appear to be predictable from
the primary structure. This is probably because the
small-residue motifs are only partially responsible for
the dimerization site, while 5–10 additional residues
partake in stabilizing interactions in the dimer inter-
face. A second reason for the lack of predictability
could be the presence of interleaved dimerization
motifs of importance for allowing two—or more—helix
interaction surfaces, which is discussed further in the
following.
Switching requires two interaction surfaces with
impact on motif conservation
Some SPTMRs have been shown to act in preformed
homodimers whose conformations are changed in
response to extracellular ligand binding [18,25,26,96].
This finding has prompted the hypothesis that at least
two biologically relevant TMD dimer conformations
exist for these SPTMRs; one corresponding to the
active receptor state (ON) and one corresponding to
the inactive state (OFF). Switching between these
states upon activation is anticipated to result in
changes in, e.g., the distance between the C and N ter-
mini or rotation of the TMD a-helices.
As noted from, e.g., the TMD primary structures
of the ErbB family, multiple small-x2-small or small-
x3-small motifs may be present in a single TMD
(Fig. 7). This has stimulated the idea that these motifs
each participate in a biologically relevant dimer inter-
face [25,97], but until recently with little experimental
support [45]. However, based on cellular studies,
chemical cross-linking, NMR data, and MD simula-
tions, it has recently been suggested that ligand-
induced activation of the ErbB1 causes switching from
an N-terminal to a C-terminal GAS-mediated TMD
dimer conformation, leading to separation of the
TMD a-helices on the intracellular side [15,17,98,99].
This rearrangement is suggested to release the
-MSEPASLLTASDL-DPLILTLSLILVLISLLLTVLALLSHRRTLQQKIW-P-
-MSEPVSLLTPSDL-DPLILTLSLILVVILVLLTVLALLSHRRALKQKIW-P-
-FTMN-DTTVWISVAVLSAVICLIIVWAVAL-KGYSMV-
-MTYFYVTDYLDVP-SNIAKIIIGPLIFVFLFSVVIGSIYLFLR-KRQPDGPL-
-MGLPGRVP-LWVILLSAFAGLLLLMLLILALWKIGFF-KRPLKKKMEKLE-
-ALEERAIP-IWWVLVGVLGGLLLLTILVLAMWK-VGFFKRNRP-
. -GPLVPRGS-MALIVLGGVAGLLLFIGLGIFFSVRS-RHRRRQAERMSQIKR...
-PESPKGPD-ILVVLLSVMGAILLIGLAALLIWKLLITIH-DRKEF-
-EQ-RASPVTFIIATVVGVLLFLILVVVVGILIKRR-R-
-MD-SAPFELFFMINTSILLIFIFIVLLIHFEGW-RI-
-VQLAHHFSEP-EITLIIFGVMAGVIGTILLISYGIRR-LIKK-
-SPPVSRGL-TGGEIVAVIFGLLLGAALLLGILVFRSR-RA-
-KI-PSIATGLVGALLLLLVVALGIGLFIRRRHIVR-KRTLRRLLQ...
-EGCPTNGKIPS-IATGMVGALLLLLVVALGIGLFMR-RRHIVRKR-
-GCPAEQRAS-PLTSIISAVVGILLVVVLGVVFGILIKRRQ-QKIRK-
-AEQRA-SPLTSIISAVVGILLVVVLGVVFGILIKRRQQ-KIRKYTMRRL...
-STLPQHAR-TPLIAAGVIGGLFILVIVGLTFAVYVRRK-SIKKKRA-
-KGAIIGLMVGGVVIATVIVITLVMLKKK-
-CSTVS-PGVLAGIVVGDLVLTVLIALAVYFLG-RL-
-DS-KLCYLLDGILFIYGVILTALFLRVKF-SRSAD-
-EFQTLSPEGSGN-LAVIGGVAVGVVLLLVLAGVGFF-IHRRRK-
-GR-THLTMALTVIAGLVVIFMMLGGTFLYWRGRRHH-HHHH-
-E-KTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGG-
-HSL-PFKVVVISAILALVVLTIISLIILIMLWQ-KKPRYE-
-LPAEEELVEADEAGS-VYAGILSYGVGFFLFILVVAAVTLC-RLR-
-QKLVFFAEDVGS-NKGAIIGLMVGGVVIATVIVITLVMLKKK-
mEPOR (2MXB)...
EPOR (2MV6)....
PRLR (PRLR)....
IR (2MFR)......
IntαI (2L8S)...
IntαIIβ (2K1A).
CD4 (2KLU).....
Intβ3 (2RMZ)...
mErbB2 (1IIJ)..
TLR3 (2MK9)....
GpA (1AFO).....
EphA1 (2K1L)...
ErbB1 (2M20)...
ErbB1 (2M0B)...
ErbB2 (2JWA)...
ErbB2 (2N2A)...
ErbB4 (2LCX)...
APP (2LZ3)..... 
DAP12 (2L34)...
ζζ (2HAC)......
EphA2 (2K9Y)...
ErbB3(2L9U)....
VEGFR2 (2M59)..
PDGFR (2L6W)...
FGFR3 (2LZL)...
APP (2LOH).....
Mo
no
me
ri
c
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gh
t-
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Fig. 7. The amino acid sequences of the
current SPTMR-TMD structures. Residues
of the a-helices are shown in bold face,
while hydrophobic side chains are gray,
polar are green, positively charged are red,
negatively charged are blue. Cys, Gly, and
Pro are orange. The sequences have been
aligned according to the extent of their a-
helices, and for the homodimers, the
residues that partake in interhelical
interactions are highlighted with a purple
box. The CD4, ErbB1 and ErbB2 sequences
have for illustrative purposes been cut short
(signified by ‘. . .’).
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intracellular JM region from the membrane bilayer,
which instead forms an antiparallel dimer, ultimately
triggering kinase activation [15,17,98]. This hypothesis
is based on MD simulations by Arkhipov et al. [17],
investigating the stability of two putative dimer con-
formations of the ErbB1-TMD formed through two
GAS-motifs located N- and C-terminally, respectively.
These simulations showed a higher stability of the
dimer formed by the Gx3G motif at the N terminus,
consistent with NMR studies of the isolated ErbB1-
TMD in bicelles (2M20) [15,17]. In contrast, the C-
terminal motif Ax3G supported a relatively unstable
ErbB1-TMD dimer, which was found to be stabilized
when other domains of the ErbB1 were present [17].
A very recently solved structure of an ErbB1-TMD
C-terminal dimer (2M0B) published by Bocharov
et al. [62] to some extent support the findings of
Arkhipov et al., with the C-terminal dimer utilizing
the predicted motif. This second dimer conformation
nevertheless deviates substantially from the C-terminal
dimer model suggested by Arkhipov et al., and has a
smaller N-terminal separation and helix crossing angle
[17,62]. Nonetheless, it has been suggested that the
ErbB1-TMD dimer structure 2M20 solved by Endres
et al. [15] represents the ON-state conformation, while
the 2M0B structure by Bocharov et al. [62] could rep-
resent the receptor OFF-state conformation. Bocharov
et al. [62] further speculated that the two different
dimer conformations of the ErbB1-TMD arise due to
differences in the membrane mimetics used, with the
assumed OFF-state solved in DPC micelles, while the
ON-state was solved in bicelles. As micelles are more
water permeable than bicelles, it is argued that the
more hydrophobic dimerization motif utilized in the
OFF-state conformation is favored in a more polar
environment, and vice versa [62]. Based on this obser-
vation, Bocharov et al. [62] suggested that the lipid
bilayer partakes in transferring ligand binding into
TMD switching. However, the primary structures of
the two studied ErbB1-TMD variants have important
differences that may play a role (Fig. 7). In the 2M20
variant, Met650 and Met668 of the TMD are substi-
tuted with Leu and Ile, respectively, the 2M0B variant
contains seven additional N-terminal residues com-
pared to the 2M20 variant, while the 2M20 variant
contains 24 additional C-terminal residues. These dif-
ferences may favor and/or disfavor, or even abolish,
interactions that are directly or indirectly involved in
dimerization, and it should be noted that M650 par-
takes in the helix–helix interaction of the 2M0B dimer
(Table 1). To confirm that the properties of the mem-
brane mimetics indeed favors different dimer confor-
mations, the occurrence of these conformations must
be confirmed with the same ErbB1-TMD variant in
different membrane mimetics.
Two different dimer conformations have similarly
been solved for the ErbB2-TMD by the same group
[58,61]. The ErbB2-TMD dimer solved in bicelles
(2JWA) appears to utilize a more polar interaction
motif (Tx3Sx2VGx2LVx2Lx3F), while the dimer confor-
mation solved in DPC micelles (2N2A) utilize a more
hydrophobic motif (Mx2ALx2LLx2ALx2GLx2R), in
agreement with the findings for the ErbB1-TMD.
However, again the primary structure of the studied
peptides differs in significant ways; the 2N2A variant
harbors 18 additional residues C-terminally compared
to the 2JWA variant, while the 2JWA variant harbors
three additional residues in the N terminus. It is there-
fore suggested by the authors that the inclusion of the
intracellular JM region in the 2N2A variant, shown to
form a parallel homodimer, may favor a different con-
formation compared to the TMDs in isolation [61].
Although the dimer conformations have not been
directly correlated with cellular studies, the authors
hypothesize that the 2JWA structure corresponds to
the ON-state conformation [58], while the 2N2A struc-
ture corresponds to the OFF-state conformation [61].
Surprisingly, the ErbB2-TMD dimer described by the
2N2A structure does not utilize the C-terminal Gx3G
motif, which has been shown to be involved in self-
association of the ErbB2-TMD in membrane bilayers
by a TOXCAT mutational study [100]. This TOXCAT
study successfully identified the Sx3G motif partaking
in the association of the N-terminal 2JWA dimer, and
is further supported by a computational study, which
found the ErbB2-TMD to homodimerize through
either of the two GAS-motifs (N and C termini), and
that the TMD could switch through rotation without
encountering a prohibitive energy barrier between the
two [97]. These conflicting results raise the question of
the degree of nativeness of the TMD homodimers in
their isolated forms and in membrane-mimicking sol-
vents, and clearly more data are required to uncover
fully the mode of signal transduction across the mem-
brane bilayer through the ErbBs. Nevertheless, the
finding of two different homodimer conformations of
the ErbB1-TMD and ErbB2-TMD are highly interest-
ing and highlight the flexibility and sensitivity of sin-
gle-pass TMD associations.
Of further note, a second dimer population has been
observed in the structural study of the EphA1 homod-
imer [65]. This second, but sparsely populated dimer
conformation appeared upon an increase of the pH
from 4.3 to 6.3, resulting in deprotonation of Glu547,
and involved a second, C-terminal GAS-motif: Ax3G
(560–564) [65]. Unfortunately, due to the small
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occupancy of this presumed second dimer conforma-
tion, structure elucidation was not possible [65]. How-
ever, based on the observed chemical shift changes, it
was proposed that this second dimer conformation
consisted of a left-handed dimer with a helix crossing
angle of ~ 30° [65], in contrast to the major populated
state which was a right-handed dimer. EphA1 has been
proposed to function as a pH sensor, and the authors
therefore speculate that the switch from a right-handed
to a left-handed homodimer structure could be related
to EphA1 signal transduction [65]. Acquisition of
transfer-NOEs to define the interaction surface of such
low-affinity and/or lowly populated dimers is compli-
cated by the low signal-to-noise and/or the limited life-
time of the complex. An alternative way of accessing
the structure of such a lowly populated dimer is
through the application of relaxation-dispersion-type
experiments [101]. These experiments have been
applied successfully to folded proteins [101,102] and
recently also to larger membrane proteins such as
phospholamban [103] and the ADP/ATP transporter
[104]. To the best of our knowledge, relaxation-
dispersion-type experiments have never been applied to
SPTMR-TMDs, but may harbor great potential in the
pursuit of the sequence-encoded dimer reorganization-
switch.
Mutations in TMDs that either activate or inactivate
SPTMRs in a cellular context provide another source
of insight into sequence-encoded switches between dif-
ferent homodimeric conformations. Currently, only
two sets of wild-type (WT)–mutant homodimer struc-
tures from SPTMRs are available; one set of the APP-
TMD [70] and one set of the VEGFR2-TMD [23]. Of
these, the structure of the APP-TMD-variant does not
relate to receptor signal transduction, leaving only one
confirmed and structurally characterized example of
both TMD ON/OFF states. In the work on the
VEGFR2-TMD, the homodimer of the constitutive
active TMD mutant T771E/F778E was found to differ
from the WT in three major aspects; enhanced propen-
sity to dimerize, higher flexibility, and a different
dimerization interface [23]. The ON-state dimerization
interface arose from a 180° rotation of the helices,
shifting the dimerization interface to the opposite side
of the helices, whereas no difference in the N- and C-
terminal gaps was observed [23]. This study implies
that the lowest energy dimer of the VEGFR2-TMD is
a predimerized OFF-state, and that activation involves
rotation to a different dimerization interface represent-
ing the ON-state.
Thus, recent studies suggest that the single-pass
TMDs are not only capable of forming one speci-
fic homodimer and that alternative states may be
favored by, e.g., point mutations, interactions of
adjacent domains, or membrane mimetics. How-
ever, the amount of data that currently exist on
homodimer switches remains sparse. Presently, the
concept of a sequence-encoded dimer-switch as a
player in receptor signal transduction remains not
only to be characterized but also to be fully vali-
dated at atomic resolution. To solve this challenge,
data on the functionality of these receptors in vivo
must be combined with atomic resolution struc-
tural studies. In the following, it will be explored
how far structural biology has come in providing
high-resolution descriptions of monomeric and
homodimeric SPTMR-TMDs.
Structural quality of the TMD
structures
Evaluation of the structural statistics
When evaluating a protein structure, two fundamen-
tally different questions are asked: (a) how well does
the structure capture the reality of the protein sam-
ple, and (b) how well does the protein sample simu-
late the native structure. The second question is too
premature to answer for SPTMR-TMDs given the
low number of structures, but has been reviewed
extensively elsewhere for membrane proteins in gen-
eral [44,105]. In the following, we will address the
first question, and solely review how reliable the
SPTMR-TMD NMR structures are in terms of rep-
resenting the reality of the protein under the experi-
mental conditions.
The quality of NMR structures is usually evaluated
on the basis of the root-mean-square deviation
(RMSD) of the structural ensemble, the Ramachan-
dran plot quality, the number of experimentally
derived structural restraints per residue, and the num-
ber of violations of the latter. In the special case of
SPTMR-TMD structures, we will focus on the ensem-
ble RMSD of all the heavy atoms in the structured
region and the number of restraints per residue
(Table 2). Factors that have not been included in the
evaluation, such as Ramachandran plot statistics,
restraints violations, and ProSA2 z-scores [106] are
overall very similar for all the structures and their val-
ues acceptable. Furthermore, dihedral angle restraints
that have been predicted by TALOS based on
observed chemical shifts have been applied in all the
structure calculations, but have not been included in
Table 2 because the relative number of predicted dihe-
dral angle restraints applied is similar for all the struc-
tures.
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Table 2. Structural statistics of available structures of WT SPTMR-TMDs.
PDB code Abbrev.
Non-native
residues Solvent
Medium-
range
NOEs
Long-
range
NOEs
Intermonomeric
NOEs
H-bond
restraints Other
RMSD,
ordered
region,
all heavy (A)
Restraints
per residue
ProSA
z-score Ref.
Monomers
2KLU CD4 Nt-GPLVPRGS DPC 178 0 – N 6.1
13.6
6.85 0.07 [54]
2MXB mEPOR -6xH-Ct DPC 53 0 – Y 1.48  0.23 1.51  1.39 [53]
2MV6 EPOR -6xH-Ct DPC 42 0 – Y 1.12  0.22 1.20  1.23 [52]
2N71 PRLR Nt-GS- DHPC 142 0 – Y
3J(HN-Ha)
couplings
0.40  0.09 5.68  0.09 [20]
2MFR IR -E-6xH-Ct DPC 22 0 – Y 1.12  0.20 0.76 1.26 [49]
1IIJ mErbB2 0 TFE N/A N/A – N N/A N/A 0.20 [51]
2L8S Int. aI -6xH-Ct LDAO 61 0 – N 32 RDCs 1.41 3.32  0.76 [46]
2RMZ Int. b3 0 Bicelle 0 0 – N 153 RDCs 0.66* 5.10  0.50 [47]
2RN0 Int. b3 0 DPC 0 0 – N 90 RDCs 0.81* 3.00  0.36 [47]
2K1A Int. aIIb Nt-G- Bicelle 78 12 – N 83 RDCs 0.8* 7.21 0.23 [48]
2LLM APP Nt-GS- DPC 75 0 – Y 1.59  0.28
0.55  0.10
2.68 0.64 [55]
2N5S ErbB1 Nt-GS-
-GG-Ct
DPC 81 0 – Y 0.86  0.31
1.70  0.22
3.12  0.51 [50]
2LP1 APP -QGRILQISITL
AAALE6xH-Ct
LMPG 22 0 – Y 63 PREs
26 RDCs
0.73
0.51
4.44 1.41 [56]
Dimers
2M20 ErbB1 -KLWS-Ct Bicelle N/A N/A 19 Y MD 0.76
1.08
N/A  0.65
0.65
[15]
2M0B ErbB1 0 DPC 128 20 20 Y 0.98  0.31 3.08  0.68
 0.67
[62]
2JWA ErbB2 0 Bicelle 106 20 20 Y MD 0.92  0.17 2.10 1.31
1.32
[58]
2N2A ErbB2 -G-Ct DPC 306 28 28 Y MD 1.18
1.86
5.22 0.39
0.51
[61]
2L9U ErbB3 Nt-M-
-R6xH-Ct
DPC 181 20 20 Y 0.91  0.14 3.05  0.23
 0.41
[59]
2LCX ErbB4 0 Bicelle 152 16 16 Y 0.83  0.17 2.90 1.68
1.8
[60]
2LZL FGFR3 0 DPC/SDS 160 26 26 Y Two side
chain to
backbone
H-bonds
0.73  0.18 3.72 1.15
1.05
[63]
2L6W PDGFR Nt-G- DPC 104 46 46 Y MD, solid
state, OCD
0.67  0.08 2.59 0.18
0.02
[64]
2M59 VEGFR2 0 DPC 164 18 18 Y MD 0.74  0.12 2.53  0.49
 0.48
[23]
2K1L EphA1 0 Bicelle 164 28 28 Y MD 0.64  0.19 3.43  1.11
 0.79
[65]
2K9Y EphA2 0 Bicelle 122 48 48 Y MD 0.86  0.24 3.70 1.05
0.46
[66]
2LZ3 APP 0 DPC 280 48 18 Y 88 RDCs 1.28  0.34 7.43 1.08
1.10
[70]
2LOH APP Nt-GS- DPC 308 14 12 Y Two side
chain to
backbone
H-bonds
1.48  0.22
1.02  0.20
5.55 0.97
0.86
[71]
2L34 DAP12 N/A N/A N/A N/A 26 N/A Disulfide
bridge
0.75 N/A 0.02
0.13
[67]
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The RMSD of a structural ensemble reports on the
precision, but not the accuracy, of the derived struc-
tures. A well-defined NMR structure of a small protein
should have an RMSD of the heavy atoms in the
structured region below 1.0 A [107]. Overall, the
RMSDs are reasonable for most of the TMD struc-
tures, but one structure stands out with a reported
RMSD of 6.1 A for the TMD helix and 13.5 A for a
minor helix (CD4). However, this high RMSD
improves by aligning only the TMD helix. For the
remaining structures, the average RMSD is 1.0 A for
the monomers, while it is 0.9 A for the homodimers.
However, not reflected in the RMSDs, but observed
when the ensembles are visually inspected, is a scissor-
like deviation in some of the dimer structures. This
lack of convergence is apparent from significant devia-
tions in the distances between the N terminus and the
C terminus, respectively, of the a-helices. In particular,
the GpA-TMD structure (1AFO) has an N- and C-
terminal deviation of 2 and 10 A, respectively, and the
APP-TMD structure (2LZ3) and the TLR3-TMD
structure have N- and C-terminal deviations of 6 and
7 A, respectively. Even though these structures pin-
point the dimerization interfaces, they provide a very
low resolution of the relative positions of the helix N
and C termini, which are critically important for inter-
preting the TMD structure in a full-receptor context.
Evaluating the accuracy of an NMR-derived struc-
ture is not straightforward. However, the number of
experimentally derived structural restraints per residue
is an important determinant. A high number of struc-
tural restraints per residue is necessary to define the
structure but does not in itself guarantee high struc-
tural reliability, whereas a low number should be
regarded as problematic. Here, we define the number
of structural restraints per residue as the sum of med-
ium-range (1 < |i  j| < 4) NOEs, long-range/inter-
monomeric NOEs, paramagnetic relaxation
enhancements (PREs), and residual dipolar couplings
(RDCs) divided by the number of residues in the
TMD a-helix (Table 2). Predicted dihedral angles are
considered indirect restraints, and we therefore found
it more transparent to not include them in the restraint
counts. In this regard, we note that when there is a
large number of NOE-derived distance restraints,
chemical shift-derived restraints play only a smaller
role in refining the structure, whereas in the case of
few distance restraints, the structure is to a large
Table 2. (Continued).
PDB code Abbrev.
Non-native
residues Solvent
Medium-
range
NOEs
Long-
range
NOEs
Intermonomeric
NOEs
H-bond
restraints Other
RMSD,
ordered
region,
all heavy (A)
Restraints
per residue
ProSA
z-score Ref.
2KPE GpA Nt-R-
-RRL-Ct
DPC 88 34 34 Y MD 0.94  018 2.26 0.70
0.60
[72]
2KPF GpA Nt-R-
-RRL-Ct
Bicelle 86 28 28 Y MD 1.07  0.15 2.20 1.29
1.11
[72]
1AFO GpA 0 DPC N/A N/A N/A N/A J-couplings 0.75 N/A 1.07
0.77
[33]
2HAC ff 0 5 : 1
DPC :
SDS
N/A N/A 46 N Disulfide
bridge,
35 RDCs
0.65 N/A 0.74
0.56
[68]
2MK9 TLR3 Nt-M- DPC 166 16 16 Y 1.07  0.18 3.03  1.03
 1.05
[69]
Except for the ProSA z-scores, the information of this table has been obtained from the published paper of each structure. Abbrev.: short
abbreviated name for the receptor of the TMD. H-bond restraints: ‘Y’ if hydrogen bond restraints were employed in the structure calculation,
‘N’ if not. Other: other structural restraints or refinements. MD is molecular dynamics simulations, while OCD is oriented circular dichroism.
RMSD, ordered region, all heavy: RMSD of the ensemble for all heavy atoms of the ordered region. ‘*’ highlights structures where the
region of the provided RMSD were not clearly defined. Restraints per residue: number of medium- and long-range NOEs, PREs, and RDCs
divided by number of residues in the ordered region of the TMD (it is assumed that the contribution from flexible regions to the total
restraint count as defined here is negligible). As a point of reference on how many restraints per residue that may be expected to be col-
lected for each TMD structure, we used the same definition to calculate the number of structural restraints per residue for three well-
defined, soluble, four-a-helix bundle proteins solved by solution-state NMR spectroscopy; the structures of prolactin [108], ACBP [109], and
AML1-ETO [110] (see main text). ProSA z-scores [106]: the ProSA z-score measures the deviation of the total energy of the structure with
respect to an energy distribution derived from random conformations [106]. Z-scores outside a range characteristic for native proteins indi-
cate erroneous structures. Z-scores were calculated for each monomer, and all structures fell within the expected range for structures of
their size. Ref.: reference describing the structure determination.
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extent supported by the dihedral angle restraints. The
fewer long-range contacts inherent to single-pass TMD
structures are expected to result in fewer NOEs per
residue than for helices in globular proteins. For com-
parison, three well-defined, soluble, four-a-helix bundle
proteins solved with solution-state NMR spectroscopy
[108–110] were found to have 10.6–11.1 structural
restraints per residue in ordered regions, which was
reduced to 5.8–6.6 restraints per residue (average of
6.1) if long-range NOEs were excluded (Table 2). With
this in mind, the SPTMR-TMD structures can be
divided into three groups; structures with <2.6
restraints per residue [10 standard deviations (STDs)
below the average of the three four-a-helix bundles],
structures with 2.6–5.0 restraints per residue (between
10 and 3 STDs below average), and structures with
more than 5.0 restraints per residue. In four cases, a
per residue dataset was not available [TMD structures
of ErbB1, GpA (1AFO), ff, DAP12]. Of the remain-
der, 8/27 structures have <2.6 restraints per residue,
12/27 have between 2.6 and 5.0 restraints per residues,
while 7/27 have more than 5.0 restraints per residue
(Table 2). It should be noted that several of the struc-
tures are additionally supported by molecular dynam-
ics (MD) simulations or data collected with other
techniques (Table 2).
As the structures of the TMDs are derived from
NMR-restraints through restrained molecular dynam-
ics simulations [107], a low number of structural
restraints essentially means that the structure determi-
nation is more similar to an unrestrained molecular
dynamics simulation (albeit currently with relatively
simple force fields). As an example, the IR-TMD
structure has with 0.76 structural restraints per residue
the lowest number of all the structures. The ensemble
has a relatively high precision (RMSD = 1.1 A); how-
ever, when the ensemble is inspected visually, it is clear
that especially the side chains have low resolution. At
the other end of the scale, the APP-TMD structure
2LZ3 has the highest number (7.43) of structural
restraints of all the structures. However, the RMSD is
higher than the average (1.3 A), and the homodimer
ensemble has N- and C-terminal deviations of 6 and
7 A, respectively, although the relative orientations of
the side chains are well defined. These two examples
illustrate how evaluation of the reliability of NMR-
derived structures is not straightforward and requires
evaluation of several factors, and highlights that for
these structures no strong correlation is apparent
between the RMSD of the structural ensembles and
the number of applied restraints (Table 2). Overall, the
current monomeric and homodimeric single-pass TMD
structures appear to have fewer experimental restraints
per residue than found for the NMR structures of sol-
uble, globular proteins.
Use of hydrogen bond restraints
Hydrogen bond restraints have not been included in
the restraint counts above, but are commonly used
(in 23 out of the 30 structures for which this infor-
mation is available). Introduction of backbone
hydrogen bonds restrain the backbone structure sig-
nificantly and should therefore be applied with cau-
tion. Due to the limited amount of tertiary structure
in single-pass TMD structures, these restraints may
act as an aid in defining the curvature of the helices,
which, however, is only truly definable through
acquisition of a sufficient set of RDCs. In some
cases, the use of the hydrogen bond restraints, and
therein the assumption of a relatively straight a-
helix, appears to be based loosely on experimental
data. In most studies, backbone amide hydrogen-to-
deuterium (H-D) exchange experiments are used as
justification for the inclusion of hydrogen bond
restraints [49,50,52,53,56,58,60,62,63,70,72], while the
origin of the assignment in other studies is unclear
[15,23,59,61,64,65,69]. As a rule of thumb, amides
engaged in hydrogen bonds exchange slowly, while
other amides exchange fast [111,112]. However, H-D
exchange rates also depend on the degree of burial
of an amide [111,113]. A study on the effects of
detergent on hydrogen exchange rates of model pep-
tides concluded that the hydrophobicity found in the
core of micelles slowed down hydrogen exchange
rates with a similar magnitude as hydrogen bonding,
an effect contributed to water exclusion by the
hydrophobic interior [114]. H-D exchange experi-
ments of membrane proteins are typically performed
by transferring the TMD-micelle complex from H2O
to D2O and evaluating which amide protons undergo
exchange with deuterium by analysis of peak intensi-
ties in 1H-15N-HSQC spectra (a methodology
described in [115]). In this way, amides that do not
exchange are identified as hydrogen bond donors.
However, in light of the above considerations, it is
problematic to use H-D exchange data as a sole
argument for the introduction of hydrogen bond
restraints in proteins embedded in membrane mimet-
ics. Residues in a kinked or curved helix, but
shielded by the micellar structure, may incorrectly be
interpreted as being engaged in a hydrogen bond,
thus leading to a straight a-helix in the resulting
structural ensemble. For these reasons, caution
should be taken in the interpretation of H-D
exchange data on membrane proteins, and these
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should not be used as a sole argument for introduc-
tion of hydrogen bond restraints. If hydrogen bond
restraints are used, they should be introduced in a
later iteration of the structure calculation, and gener-
ally only when the structure is otherwise significantly
supported by, e.g., NOEs or coupling constants
[116].
Examples where hydrogen bond restraints may
potentially have overly constrained the structures are
the monomeric structures of the mouse and human
EPOR-TMDs (2MXB, 2MV6) [52,53] (Fig. 2). As
mentioned, these structures consist of one straight a-
helix that does not only comprise the predicted TMD
region but also continues 10 residues into their JM
regions without any apparent flexibility [52,53]. How-
ever, no NOEs have been assigned for H249-L253 of
the hEPOR-TMD or around H249 of the mEPOR-
TMD, backbone relaxation data for both EPOR-
TMDs revealed increased internal dynamics in the JM
region, and the H-D exchange experiments only sup-
ported slow exchange of the backbone amides until
L246 [52,53]. Furthermore, when the secondary chemi-
cal shifts (SCSs) are calculated based on the deposited
Ca and Ha chemical shifts and predicted Ca and Ha
random coil chemical shifts from Refs. [117,118], it is
evident that a lower propensity for a-helical structure
is found in the JM region. As the currently available
predicted random coil chemical shifts are based on
data collected in isotropic aqueous solvents, exact esti-
mation of the a-helix population in the EPOR-JM is
precluded by the presence of detergents. However, the
relative differences in the average SCSs suggest an
~ 50% reduction of the a-helix population in the JM
regions compared to the TMDs. Thus, no direct exper-
imental evidence appears to support that the fully
formed TMD a-helix extend into the JM region, but
due to an overall low amount of restraints (Table 2),
excessive restraining may not cause violations in this
case. Furthermore, because these regions appear to
consist of a mixture of helical and nonhelical confor-
mations, ensemble refinement, or other ensemble mod-
eling methods may be required to determine such
flexible conformations.
Low resolution suggested by doubly determined
structures
As mentioned above, inconsistencies between doubly
determined structures are present in the collection. The
structures of five different receptor TMDs have been
solved by different groups: the homodimer of the GpA-
TMD (2KPE/2KPF vs. 1AFO), the monomer of the
APP-TMD (2LLM vs. 2LP1), the homodimer of the
APP-TMD (2LZ3 vs. 2LOH), the homodimer/mono-
mer of the ErbB1-TMD (2M0B vs. 2M20 vs. 3N5S),
and the homodimer of the ErbB2-TMD (2N2A vs.
2JWA). Of these, 2M0B vs. 2M20 and 2N2A vs. 2JWA
represent unique dimer structures, discussed above,
while the similar structures will be discussed below.
The GpA-TMD homodimers, solved in DPC
micelles and DMPC bicelles by two different groups
(1AFO in DPC micelles [33], and 2KPE and 2KPF in
DPC micelles and DMPC bicelles, respectively [72])
have very similar backbone structures. Only a small
deviation in the last helical turn is immediately appar-
ent, giving a variation in the helical C-terminal dis-
tances of 2.5 A between the structures solved in DPC.
However, when the side-chain conformations are com-
pared, numerous differences are found. The RMSD of
the heavy atoms in the helical region between the two
structural ensembles solved in DPC is 3.1 A (1AFO
vs. 2KPE), while, surprisingly, the RMSD of the heavy
atoms in the helical region between the 1AFO solved
in DPC micelles and 2KPF solved in bicelles is only
2.9 A (solved by two different groups). It thus appears
that the observed differences are not related to differ-
ences in the applied membrane mimetics. For compar-
ison, the same region has an RMSD of all heavy
atoms in the helical region of 2.8 A between the GpA
in DPC (2KPE) and in bicelles (2KPF) when solved
by the same group. Both 1AFO and 2KPE/2KPF are
primarily supported by NOEs (Table 2), but side-
chain dihedral restraints derived from quantitative
J-couplings have additionally been applied in the struc-
ture calculation of 1AFO [33]. Upon visual inspection
of the structural ensembles, the accuracy of the side-
chain conformations appears higher in the 2KPE/
2KPF structures and Ile88 (shown to make interhelical
interactions in the 2KPE/2KPF structures) is slightly
turned away from the dimerization interface in the
1AFO structure. It should nonetheless be noted that
1AFO is a pioneering structure of the field solved
14 years earlier than the 2KPE/2KPF structures.
The monomeric structures of the APP-TMD
solved by two different groups in two different deter-
gents (2LLM in DPC [55] and 2LP1 in LMPG [56]),
are clearly different. The RMSD of the heavy atoms
in the major helix region of the two structures is
4.2 A, and compared to 2LLM, the 2LP1 structure
has a major kink near Gly708 and Gly709. The
presence of this kink was confirmed by EPR double
electron–electron resonance experiments on the APP-
TMD in lipid vesicles [56]. None of the structures
have a high number of restraints per residues, and
the 2LP1 structure has no reported NOEs between
side chains [56].
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Two different groups have solved the structure of
the homodimeric APP-TMD in DPC micelles (2LZ3
[70] and 2LOH [71]), with the 2LZ3 structure being a
right-handed dimer and the 2LOH a left-handed
dimer. With a helix crossing angle of  25°, 2LZ3 is
along with 2N2A and 2M0B part of an outlier group
of the right-handed group II, denoted II* (Fig. 6). The
helix crossing angle of the left-handed structure 2LOH
on the other hand fits well within the left-handed
group III with a crossing angle of 23° (Fig. 6). It is
also evident that the curvature of the two structures is
slightly different, though exact comparison of the two
structures is complicated by the different handedness
of the helix–helix packing. Even though the two struc-
tures employ almost the same dimerization motif
(Table 1), slight differences are also observed here.
Val710 and Val717 participate in the interhelical inter-
actions in the 2LZ3 structure but not in 2LOH, while
Leu723 forms interhelical interactions in the 2LOH
structure, but not in 2LZ3.
The homodimeric structure of the ErbB1-TMD
including the JM region has been solved in DMPC
bicelles by Endres et al. [15]. Recently, a paper by
Arseniev et al. [50], describing the structure of mono-
meric ErbB1-TMD-JM in DPC micelles, also pre-
sented results on a dimeric ErbB1-TMD-JM structure
in DMPC bicelles in apparent conflict with those pre-
sented by Endres et al. [15,50]. As argued by Arseniev
et al. [50], the differences essentially boil down to the
validation of dimer formation under the applied condi-
tions and discrepancies in the data collected on the JM
region by the two groups [50]. However, and as noted
above, the ErbB1-TMD-JM variant studied by Endres
et al. [15] harbors the substitutions M650L and
M668I, is seven residues longer, and contains an addi-
tional KLWS sequence at its C terminus compared to
that studied by Arseniev et al. [50]. Thus, this may
effectively change the molecular properties of the
ErbB1-TMD and hence be the origin of the differ-
ences. If so, this further supports that the properties of
SPTMR-TMDs are highly sensitive to even small
changes in sequence, also when these are far from the
dimer interaction site. This may be a consequence of
additional lipid/detergent–protein– or protein–protein
interactions leading to allosteric changes.
In summary, it is concerning that all the double-
determined structures have discrepancies bigger than
expected from their accuracies, which raise further
concern regarding quality, reproducibility, or influence
by changes in construct-length and/or experimental
conditions. Due to the essential roles of the SPTMR-
TMDs in the very delicate signal transduction of their
receptor, high-resolution structures also at various
conditions are required if a more profound under-
standing of these mechanisms are to be obtained.
Utilizing the full NMR toolbox
As evident from Table 2 and outlined above, only a
modest number of NOE restraints have been collected
on the currently solved SPTMR-TMD structures as a
group. The reason for the poor output of NOEs from
single-pass TMDs is probably multifold,
with increased linewidth due to the large-sized micelle–
protein complexes, few protein–protein contacts, and
transient interactions as the suspected main causes
[40,119,120]. With the inadequacy of the usual primary
NMR-work horse, the NOE, additional restraints, as
well as new or optimized NMR methods are evidently
needed to increase the qualities of the structures of
these proteins. One possibility is to increase the use of
RDCs, which are unique in being global restraints. An
adequate set of RDCs in principle allows for the deter-
mination of the global relative orientation of atomic
bonds [121], which is particularly useful for SPTMR-
TMD structures for defining the a-helical curvature.
The downside of this method nonetheless is the need
for partial alignment of the protein, which can be of
significant technical challenge for membrane proteins
in particular. For the six SPTMR-TMDs structures
solved with the aid of RDCs (Table 2), weak align-
ment of the micelle-embedded TMDs was accom-
plished using strain-induced alignment in a
polyacrylamide gel [46–48,56,68,70], in addition to G-
tetrad DNA for the APP-TMD structure 2LZ3 [70].
Another option already available in the NMR toolbox
is the measurement of long-range distances using PREs
induced by paramagnetic spin labels. The introduction
of a paramagnetic center in a TMD enhances the relax-
ation process of nearby nuclei and thus lowers the inten-
sity of the NMR signals in its surroundings in a
distance-dependent manner, which may be converted to
distance restraints for structure calculations [122]. PRE
restraints cover longer distances than NOEs (10–25 A),
but are less precise [123]. However, a systematic study
has shown that PRE-derived distance restraints may
provide sufficient data to obtain a backbone structure of
a-helical membrane proteins with an accuracy of 1.5 A
(backbone RMSD) [119]. PREs have so far only been
utilized to collect distance restraints for one SPTMR-
TMD, the monomeric APP-TMD structure 2LP1 [56].
Hence, as an alternative to collecting more compre-
hensive sets of NOEs, we suggest that improved accu-
racy and precision of SPTMR-TMD structures may be
obtained by measuring both RDCs and PREs. Fur-
thermore, MD simulations of the experimentally
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determined structures are often performed to support
the experimental data [15,23,58,63–66,72], which with
the continuous improvement of force fields may be of
even further value in the future [124]. In this regard, it
should also be noted that NMR structure calculations
in general involve MD simulations with the experimen-
tal data as restraints. These are currently performed in
vacuum, typically with the option of additional refine-
ment in water. It is unclear how these approximations
affect TMD structures, and future efforts to allow
refinement in a micelle or lipid bilayer may be reward-
ing in terms of improving the precision. We note, how-
ever, that to make this possible, we need to have a
better understanding of the structural properties of the
membrane mimetics used, and how the SPTMR-
TMDs are embedded within them. Finally, increased
access to affordable fully deuterated detergents and
lipids could allow for more groups to engage in the
endeavor as well as increase the quality of the 13C-
detected NOESY spectra considerably.
Are we missing out on the dynamic
oligomeric state? How to study a
symmetric and flexible dimer?
Gaining control of a weak dimer
The low number of currently available homodimeric
TMD structures from SPTMRs is likely a reflection of
the challenges associated with structural studies of
these symmetric and flexible dimers. A high conforma-
tional flexibility and modest affinity of the TMD
homodimers are presumably a prerequisite for their
anticipated ability to switch between conformations;
these properties however also clearly challenge struc-
tural studies of SPTMR-TMD dimers. As discussed,
the overall quality of the available structures appears
limited, and, in addition, the oligomeric state of the
protein is not always clearly defined. The homodimeric
state of most of the TMDs has mainly been confirmed
under the applied conditions by acquisition of interhe-
lical NOEs [15,23,58–63,65,66,69,71,72], sometimes in
combination with cross-linking experiments [64] or
with the detection of size changes as estimated from
backbone relaxation rates [61,62,69] or ultracentrifuga-
tion [70]. Interhelical NOEs obtained in filter-based
experiments should preferably be compared to back-
ground reference spectra of the protein in the absence
of unlabeled protein to avoid misinterpretation of
strong intramolecular peaks leaking through the filter
due to imperfect isotope labeling [50], but it is rarely
clear if these have been acquired. In the structural
studies of the monomeric TMDs, it is also not always
shown that the TMD is in fact monomeric under the
applied conditions. This lack of evaluation of the oli-
gomeric state is probably a result of the complications
introduced by their embedment in membrane mimetics,
which renders classical size estimations dependent on
two unknowns (the extent of oligomerization of the
protein and the size of the membrane mimetics).
Detection of interhelical NOEs is, when used properly,
a reliable measure of a significant population of dimer.
Nonetheless, interspecies NOEs are resource-heavy
measurements that are not suitable for evaluating large
sets of conditions and are not easily, if at all possible,
acquired on transiently interacting proteins [120]. Fur-
thermore, they are not appropriate to confirm the
absence of oligomerization for studies of the mono-
meric state. A possible strategy is utilization of param-
agnetic tags [48], the implementation of which
nonetheless may require prior knowledge of the dimer-
ization site, the generation of a series of mutants, as
well as additional technical challenges associated with
the use of hydrophobic labels in the context of a mem-
brane-mimicking environment. Thus, development of
high-throughput methods for reliable determination of
the oligomeric state of micelle-embedded TMDs under
a large set of NMR-suitable conditions is essential for
the development of the field. One promising lead is the
recent development of native mass spectrometry on
membrane proteins, allowing acquisition of spectra on
intact membrane protein complexes embedded in
micelles [125]. These methods are, however, still not
sufficiently quantitative to determine the extent of
oligomerization.
A particular challenge is that of stabilizing mem-
brane protein oligomers in non-native membrane
mimetics. It is becoming increasingly clear that the
lipid bilayer may participate in TMD associations
through sequence independent effects such as mem-
brane thickness and charge [126,127]. Furthermore,
sequence dependent effects mediating specific lipid
binding to TMD helices have been suggested to play
important roles in the regulation of the monomer–
dimer equilibrium, both by counteracting and enhanc-
ing dimerization [128]. These effects are naturally not
well simulated in the membrane mimetics that allow
structural studies by solution-state NMR spectroscopy,
putatively destabilizing the TMD homodimers further.
Several studies have reported that the monomer–dimer
equilibrium for some TMDs may be manipulated, and
thereby studied, through changes in the detergent-to-
protein (DP) or lipid-to-protein (LP) ratio, as first
reported by Fisher et al. [129] on the GpA-TMD. This
is essentially analogous to the common approach of
diluting a protein complex with the purpose of pushing
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the equilibrium toward the monomer conformation to
allow its dissociation constant to be determined. In
addition to GpA, monomer–dimer transitions as a
result of changes in the DP ratio have been reported
for many of the TMDs of which structures have been
reported, e.g., the homodimers of FGFR3, VEGFR,
ErbB1-4, APP, and TLR3 [23,59–63,69,71,130].
Solution-state NMR spectroscopy is a powerful tool
for studying monomer–dimer transitions as a conse-
quence of changes in e.g., DP ratio, offering detection
and residue-level mapping of the formation and disso-
ciation of low to moderate affinity complexes, such as
e.g., homodimers, as well as providing structural infor-
mation. Even in cases where multiple oligomeric states
occur simultaneously, data may under certain condi-
tions be extracted and assigned to each state. Method-
ologies for utilizing solution-state NMR spectroscopy
for investigation of TMD oligomerization based on
manipulating the DP or LP ratio have been developed
[130,131]; however, a high-throughput method for con-
firming that the chemical shift changes observed stem
from changes in oligomeric states is still desirable. The
major drawback is additionally that the detergent con-
centrations applicable for NMR studies have both
upper and lower limits. The upper limit is caused by
an increase in sample viscosity, and thereby a slow-
down in molecular tumbling, leading to line broaden-
ing [132], with the exact concentration limit dependent
on the nature of the detergent and the experimental
conditions. The lower limit arises because it is difficult
to properly analyze data obtained with detergent con-
centrations below the critical micelle concentration
(CMC) of the detergent, as the nature of protein/deter-
gent micelles under these conditions is poorly under-
stood. Consequently, only systems undergoing
complete monomer–dimer transitions within the appli-
cable detergent range are interpretable. Furthermore,
with the exception of APP-TMD in LMPG micelles
[130], the majority of TMD-detergent systems studied
so far exhibit slow exchange on the NMR timescale of
the monomer–dimer transition. Consequently, NMR
methodologies for quantitatively studying systems in
fast exchange are still lacking behind.
Solution-state NMR studies of the TMD
monomer–dimer transition
Determining the kinetics of monomer–dimer transi-
tions in detergent solvent is a rather complex case,
in which factors imposed by the solvent system, such
as the CMC, properties and participation of the
detergent, as well as micellar collisions are possible
contributors to the observed behavior. Several
models have been proposed to aid the derivation of
formalisms to describe the oligomerization of single-
pass TMDs in such systems: the continuous solvent
model [133,134], the detergent-release model
[129,134], and the micellar solvent model [131]. In
essence, the continuous solvent model assumes that
the detergent acts as a solvent in the dimerization
process, i.e., that dimerization in micellar solvent
behaves similarly to dimerization in water or a lipid
bilayer. Such an assumption is mainly applicable
when the monomer–dimer transition occurs within
the same micelle (e.g., at low DP ratio). In the
detergent-release model, the detergent is not treated
as a solvent but rather as a participant in the dimer-
ization process, a description found best applicable
at a high DP ratio and to relatively strong dimers.
Lastly, the micellar solvent model is based on the
assumption that dimerization and dissociation occur
only upon collision and decay of the micelles,
respectively. The associated formalism only applies
when the micelle collisions are frequent and the
dimer dissociation rates are slow on the NMR time-
scale, and transitions within a single micelle therefore
become negligible. A detailed description of all the
models and formalisms for describing the equilibrium
can be found in Ref. [131]. That no single formalism
or model is capable of describing all monomer–dimer
transitions highlights their complexity, and that
much remains to be understood. The homodimeriza-
tion of the APP-TMD has for example been studied
in both DPC micelles [71] and in LMPG micelles
[130], where the monomer–dimer is in slow exchange
on the NMR timescale in DPC, but in fast exchange
in LMPG. That is, the monomer–dimer transition of
the APP-TMD fits within the detergent-release model
and the continuous solvent model, depending on the
detergent rather than the intrinsic nature of the
TMD association. This is in line with the observa-
tion that the magnitude of the dimer dissociation
constant is dependent on the applied detergent
[129,134], and thus the question of the biological rel-
evance of such estimations of the equilibrium kinet-
ics may be raised. Even when these measurements
are conducted in lipid bilayers, the strength of the
associations varies considerably with membrane com-
position [126,127], a scenario which might reflect
biological relevance. It can be argued, as suggested
by Mineev et al. [131], that these estimations may be
used to compare the strength of dimer formation of
TMDs measured in the same membrane-mimicking
environment. However, as mentioned, different deter-
gents and lipids do not affect structure, stability,
and functionality of membrane proteins similarly and
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this interplay is currently not well understood. The
question is therefore if the same membrane mimetic
environment also affects different TMD monomer–
dimer equilibria differently, and the measured equi-
librium kinetics thus becomes an equation with too
many unknowns to provide any biologically mean-
ingful results. It should be noted that most of these
studies have been conducted on the GpA-TMD only,
which is generally considered to form a very stable
homodimer [135], presumable also more tolerant to
varying conditions.
In terms of atomic resolution structural knowledge
on the monomer–dimer transition, only the TMDs of
ErbB1, ErbB2, and APP are represented by structures
of both a monomer and a homodimer, and in case of
ErbB2, the monomer and dimer does not originate
from the same species. Additionally, as discussed, con-
troversy around the structures of the ErbB1-TMD
exists, while the characteristics of the APP-TMD are
unclear due to the multiple structures representing the
monomeric and dimeric APP-TMD. Consequently, lit-
tle direct knowledge is available on the details of the
structural transformation of the TMDs upon monomer
to dimer transition. The handful of monomeric, helical
TMDs, however, clearly demonstrates that the forma-
tion of secondary structure is uncoupled from
oligomerization. It should, however, be noted that the
ErbB1-TMD a-helix has been found to be extended
upon homodimerization [62].
When biology awaits biophysics
From our analyses of the contemporary structures of
SPTMR-TMDs, we were surprised to discover that
over a period of almost 20 years since the first struc-
ture was reported [33], only a total of 27 unique struc-
tures are now available, representing 21 receptors.
Given the abundance of these proteins in the eukary-
otic proteome with more than 1300 different SPTMRs
in humans alone, this means that <2% currently act as
structural representatives of the entire family. Thus,
structural biology is critically lacking behind, and the
time where we will be able to extract general proper-
ties, where the structures are so many that they will
generate predictive power and when we are able to elu-
cidate molecular mechanisms is not even within eye-
sight. Moreover, as we have highlighted, the quality of
the limited number of structures is not always on par
with expected standards and the situation has resem-
blance to when the first X-ray structure of myoglobin
appeared. This is clearly a problematic situation; the
design of TMD-specific pharmaceutical agents, predic-
tion or rationalization of mutational affects in relation
to disease, and deciphering of functional mechanisms
require high resolution, especially when dealing with a
domain carrying so much functionality in so few resi-
dues. With the current pace of 1–2 structures solved
per year, we have to wait more than 100 years to
reach completeness. Adding to this, only the surface
has been scratched in terms of evaluating how well the
determined structures in membrane mimetics actually
represent the reality found in the native membrane
bilayer. In this respect, the environmental properties
may take on an equally big and convoluted role, and
in a cellular context dynamical changes in the lipid
composition constantly occur as a result of metabolic
changes, which are often close to and even mediated
by lipid-binding motifs in the membrane protein itself
[128]. Thus, the Anfinsen dogma of how the protein
fold is determined by the interplay between the pri-
mary structure and its environment must not be
neglected.
The question is why these proteins are so problem-
atic and what obstacles are holding the field back?
One of the issues is, as discussed, the conformational
flexibility in terms of the oligomeric state inherent to
these TMDs, and this property challenges the field of
structural biology in more ways than merely pushing
at the boundaries of the current techniques. The signal
transduction model for SPTMRs shown to be dimeric
prior to ligand binding is anticipated to entail at least
two biologically relevant dimer conformations—the
ON- and the OFF-states. However, as structural stud-
ies of single-pass TMDs are currently conducted on
the TMDs in isolation, detached from the ECD and
the ICD, it cannot be directly deduced if the structural
state of lowest energy present in the NMR tube is the
ON- or OFF-state, or neither. Therefore, validation
and interpretation of the structural findings through
cellular studies are of paramount importance for the
field and coupling between structural biology and cell
biology a necessity.
Clearly, plenty of challenges remain to be tackled
in the structural studies of these seemingly simple, but
intriguingly complex domains, and we have below
highlighted a few of the outstanding questions (Box
1). Some issues may be relieved to some extent by
other techniques than the currently dominating solu-
tion-state NMR spectroscopy entering the scene of
SPTMR-TMD structures. Solid-state NMR spec-
troscopy is emerging as a promising tool for struc-
tural studies of membrane proteins, especially because
it allows applications of more native-like membrane
bilayers [136]. However, solid-state NMR spec-
troscopy does not have the year-long proficiency in
structure determination as solution-state NMR, with
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only 81 deposited structures in the PDB [32], but is
developing fast. Furthermore, this technique requires
significantly higher amounts of isotope-labeled protein
than solution-state NMR, which nonetheless is
increasingly resolved by the development of new effi-
cient production schemes [34,137,138].
Lastly, with the increased resolution obtained with
cryo-electron microscopy [139–141], it is possible that
within the coming decade, it will be possible to resolve
entire SPTMR structures including the ECD and the
ICD. This will provide a major breakthrough for
structural biology in general and for cellular signaling
in particular, but it will not be possible before full
receptors can be produced, purified, and stabilized in
sufficient amounts. Until then, solution-state NMR
spectroscopy may have to carry the torch alone.
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• How can different dimer conformations be studied and linked to functionally different receptor states?
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